High resolution microdialysis. Methodological issues and application to the study of inflammatory brain response;Microdiálisis de alta resolución. Aspectos metodológicos y aplicación al estudio de la respuesta inflamatoria cerebral

Neurocirugia

Volumn 20, Issue 5, 2009, Pages 433-447

  De Los Rios, J A ^a   Sahuquillo, Juan ^a   Merino, M A ^a   Poca, M A ^a   Exposito L ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Chemokines; Cytokines; Membrane cut off; Microdialysis; Neuroinflammation; Relative recovery; Traumatic brain injury

Indexed keywords

GELATINASE A; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE; METALLOPROTEINASE; NERVE PROTEIN;

BRAIN FUNCTION; BRAIN INJURY; DIALYSIS CATHETER; DIALYSIS MEMBRANE; DIFFUSION COEFFICIENT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MACROMOLECULE; MICRODIALYSIS; MOLECULAR DYNAMICS; MONITORING; NERVOUS SYSTEM INFLAMMATION; PROTEOMICS; REVIEW; TEMPERATURE; ULTRAFILTRATION; ANIMAL; ARTIFICIAL MEMBRANE; BRAIN LEVEL; CHEMICAL STRUCTURE; CHEMISTRY; DIFFUSION; ENCEPHALITIS; HEAD INJURY; INSTRUMENTATION; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PERFUSION; PHYSIOLOGY; PROTEIN CONFORMATION;

ANIMALS; BRAIN CHEMISTRY; CRANIOCEREBRAL TRAUMA; CYTOKINES; DIFFUSION; ENCEPHALITIS; HUMANS; INFLAMMATION MEDIATORS; MEMBRANES, ARTIFICIAL; METALLOPROTEASES; MICRODIALYSIS; MODELS, MOLECULAR; NERVE TISSUE PROTEINS; PERFUSION; PROTEIN CONFORMATION; ULTRAFILTRATION;

EID: 73949155533     PISSN: 11301473     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1130-1473(09)70140-x     Document Type: Review

References (109)

1. th. Madrid: Elsevier España,S.A., 2004, pp 243-274.
2. Alessandri, B., Doppenberg, E.M., Bullock, M.R.R., et al,: Glucose and metabolism after severe human head injury: influence of excitatory neurotransmitters and injury type. Acta Neurochir Suppl (Wien) 1999; 75: 21-24.
3. Allan, S.M., Rothwell, N.J.: Cytokines and acute neurodegeneration. Nat.Rev.Neurosci.2001; 2: 734-744.
4. Amberg, G., Lindefors, N.: Intracerebral microdialysis: II. Mathematical studies of diffusion kinetics. J. Pharmacol. Methods 1989; 22: 157-183.
5. Andrade, J.D., Hlady, V.: Vroman effects, techniques, and philosophies. J. Biomater. Sci. Polym. Ed 1991; 2: 161-172.
6. Ao, X., Rotundo, R.F., Loegering, D.J., et al.: In vivo microdialysis sampling of cytokines produced in mice given bacterial lipopolysaccharide. J. Microbiol. Methods 2005; 62: 327-336.
7. Ao, X., Sellati, T.J., Stenken, J.A.: Enhanced microdialysis relative recovery of inflammatory cytokines using antibody-coated microspheres analyzed by flow cytometry. Anal. Chem. 2004; 76: 3777-3784.
8. Ao, X., Stenken, J.A.: Microdialysis sampling of cytokines. Methods 2006; 38: 331-341.
9. Arvin, B., Neville, L.F., Barone, F.C., et al.: The role of inflammation and cytokines in brain injury. Neurosci. Biobehav. Rev 1996; 20: 445-452.
10. th. Oxford: Oxford University Press, 1994, pp 817-860.
11. Basu, A., Krady, J.K., Levison, S.W.: Interleukin-1: a master regulator of neuroinflammation. J. Neurosci. Res. 2004; 78: 151-156.
12. Bellander, B.M., Cantais, E., Enblad, P.,. et al.: Consensus meeting on microdialysis in neurointensive care. Intensive Care Med 2004; 2166-2169.
13. Benveniste, H.: Brain microdialysis. J Neurochem 1989; 1667-1679.
14. Benveniste, H., Hansen, A.J., Ottosen, N.S.: Determination of brain interstitial concentrations by microdialysis. J Neurochem 1989; 52: 1741-1750.
15. Berman, H.M., Westbrook, J., Feng, Z., et al.: The Protein Data Bank. Nucleic Acids Res. 2000; 28: 235-242.
16. Bourne, J.A.: Intracerebral microdialysis: 30 years as a tool for the neuroscientist. Clin. Exp. Pharmacol. Physiol 2003; 30: 16-24.
17. Brown, S.A., Mayberry, A.J., Mathy, J.A., et al.: The effect of muscle flap transposition to the fracture site on TNFalpha levels during fracture healing. Plast. Reconstr. Surg. 2000; 105: 991-998.
18. Brunner, M., Langer, O.: Microdialysis versus other techniques for the clinical assessment of in vivo tissue drug distribution. AAPS.J.2006; 8: E263-E271.
19. nd. London: Hodder Arnold, 2005, pp 113-139.
20. Bungay, P.M., Dedrick, R.L., Fox, E., et al.: Probe calibration in transient microdialysis in vivo. Pharm. Res. 2001; 18: 361-366.
21. Bungay, P.M., Morrison, P.F., Dedrick, R.L.: Steadystate theory for quantitative microdialysis of solutes and water in vivo and in vitro. Life Sci. 1990; 46: 105-119.
22. Bungay, P.M., Newton-Vinson, P., Isele, W., et al.: Microdialysis of dopamine interpreted with quantitative model incorporating probe implantation trauma. J. Neurochem. 2003; 86: 932-946.
23. Chakraborti, S., Mandal, M., Das, S., et al.: Regulation of matrix metalloproteinases: an overview. Mol. Cell Biochem 2003; 253: 269-285.
24. Chavarria, A., Alcocer-Varela, J.: Is damage in central nervous system due to inflammation? Autoimmun. Rev 2004; 3: 251-260.
25. Chen, J., Anderson, J.B., DeWeese-Scott, C., et al.: MMDB: Entrez's 3D-structure database. Nucleic Acids Res. 2003; 31: 474-477.
26. Chen, K.C., Hoistad, M., Kehr, J., et al.: Theory relating in vitro and in vivo microdialysis with one or two probes. J. Neurochem. 2002; 81: 108-121.
27. Clapp-Lilly, K.L., Roberts, R.C., Duffy, L.K., et al.: An ultrastructural analysis of tissue surrounding a microdialysis probe. J. Neurosci. Methods 1999; 90: 129-142.
28. CMA Microdialysis: CMA 71 High Cut-Off Brain Microdialysis Catheter. CMA Microdialysis Product Notes 2006.
29. Csuka, E., Morganti-Kossmann, M.C., Lenzlinger, P.M., et al.: IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function. J. Neuroimmunol. 1999; 101: 211-221.
30. DeFranco, A.L., Locksley, R.M., Robertson, M.: Immunity, The Immune Response in Infectious and Inflammatory Disease. London: New Science Press Ltd, 2007.
31. Dostalova, I., Pacak, K., Nedvidkova, J.: Application of in vivo microdialysis to measure leptin concentrations in adipose tissue. Int. J. Biol. Macromol. 2003; 32: 205-208.
32. Duo, J., Fletcher, H., Stenken, J.A.: Natural and synthetic affinity agents as microdialysis sampling mass transport enhancers: Current progress and future perspectives. Biosens. Bioelectron. 2006.
33. Eck, M.J., Sprang, S.R.: The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding. J. Biol. Chem. 1989; 264: 17595-17605.
34. Engstrom, M., Polito, A., Reinstrup, P., et al.: Intracerebral microdialysis in severe brain trauma: the importance of catheter location. J. Neurosurg. 2005; 102: 460-469.
35. Fassbender, K., Schneider, S., Bertsch, T., et al.: Temporal profile of release of interleukin-1beta in neurotrauma. Neurosci.,Lett. 2000; 284: 135-138.
36. Goodman, J.C., Valadka, A.B., Gopinath, S.P., et al.: Extracellular lactate and glucose alterations in the brain after head injury measured by microdialysis. Crit Care Med 1999; 27: 1965-1973.
37. Gosavi, S., Chavez, L.L., Jennings, P.A., et al.: Topological frustration and the folding of interleukin-1 beta. J. Mol. Biol. 2006; 357: 986-996.
38. Gosselin, D., Rivest, S.: Role of IL-1 and TNF in the brain: twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system. Brain Behav. Immun. 2007; 21: 281-289.
39. Gottschall, P.E., Yu, X.: Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem1995; 1513-1520.
40. th. Madrid: Elsevier Inc., 2004, pp 181-194.
41. Hamrin, K., Rosdahl, H., Ungerstedt, U., et al.: Microdialysis in human skeletal muscle: effects of adding a colloid to the perfusate. J Appl Physiol 2002; 92: 385-393.
42. Hillered, L.: Neurochemical monitoring of the acutely injured human brain. Scand J Clin Lab Invest 1999; 59: 9-18.
43. Hillered, L., Persson, L.: Microdialysis for neurochemical monitoring of the human brain. Scand. Cardiovasc. J. 2003; 37: 13-17.
44. Hillered, L., Vespa, P.M., Hovda, D.A.: Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis. J Neurotrauma 2005; 22: 3-41.
45. Hillman, J., Aneman, O., Anderson, C., et al.: A microdialysis technique for routine measurement of macromolecules in the injured human brain. Neurosurgery 2005; 56: 1264-1268.
46. Hillman, J., Aneman, O., Persson, M., et al.: Variations in the response of interleukins in neurosurgical intensive care patients monitored using intracerebral microdialysis. J. Neurosurg. 2007; 106: 820-825.
47. Hillman, J., Milos, P., Yu, Z.Q., et al.: Intracerebral microdialysis in neurosurgical intensive care patients utilising catheters with different molecular cut-off (20 and 100 kD). Acta Neurochir. (Wien.) 2006; 148: 319-324.
48. Holmin, S., Hojeberg, B.: In situ detection of intracerebral cytokine expression after human brain contusion. Neurosci Lett 2004; 369: 108-114.
49. Hrabe, J., Hrabetova, S., Segeth, K.: A model of effective diffusion and tortuosity in the extracellular space of the brain. Biophys. J. 2004; 87: 1606-1617.
50. Hutchinson, P.J.: Microdialysis in traumatic brain injury - methodology and pathophysiology. Acta Neurochir. Suppl 2005; 95: 441-445.
51. Hutchinson, P.J., O'Connell, M.T., Nortje, J., et al.: Cerebral microdialysis methodology - evaluation of 20 kDa and 100 kDa catheters. Physiol Meas. 2005; 26: 423-428.
52. Hutchinson, P.J., O'Connell, M.T., Rothwell, N.J., et al.: Inflammation in human brain injury: intracerebral concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1ra. J.Neurotrauma 2007; 24: 1545-1557.
53. Kushi, H., Saito, T., Makino, K., et al.: Neuronal damage in pericontusional edema zone. Acta Neurochir. Suppl 2003; 339-342.
54. Lau, L.T., Yu, A.C.: Astrocytes produce and release interleukin-1, interleukin-6, tumor necrosis factor alpha and interferon-gamma following traumatic and metabolic injury. J. Neurotrauma 2001; 18: 351-359.
55. Lindefors, N., Amberg, G., Ungerstedt, U.: Intracerebral microdialysis: I. Experimental studies of diffusion kinetics. J. Pharmacol. Methods 1989; 22: 141-156.
56. Lo, E.H., Wang, X., Cuzner, M.L.: Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J Neurosci. Res 2002; 69: 1-9.
57. Locksley, R.M., Killeen, N., Lenardo, M.J.: The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104: 487-501.
58. Lonnroth, P., Jansson, P.A., Smith, U.: A microdialysis method allowing characterization of intercellular water space in humans. Am. J. Physiol 1987; 253: E228-E231.
59. Male, D.: Introducción al sistema immunitario, in Male D, Brostoff J, Roth DB, et al (eds): Immunología, ed 7. Madrid: Elsevier, 2007, pp 3-18.
60. Male, D.: Mecanismos de immunidad innata, in Male D, Brostoff J, Roth DB, et al (eds): Immunología, ed 7. Madrid: Elsevier, 2007, pp 3-18.
61. Maurer, M.H., Berger, C., Wolf, M., et al.: The proteome of human brain microdialysate. Proteome. Sci. 7, 2003.
62. Mellergard, P., Aneman, O., Sjogren, F., et al.: Changes in extracellular concentrations of some cytokines, chemokines, and neurotrophic factors after insertion of intracerebral microdialysis catheters in neurosurgical patients. Neurosurgery 2008; 62: 151-157.
63. Montaner, J., Molina, C.A., Monasterio, J., et al.: Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 2003; 107: 598-603.
64. Moore, K.W., de Waal, M.R., Coffman, R.L., et al.: Interleukin-10 and the interleukin-10 receptor. Annu.Rev.Immunol. 2001; 19: 683-765.
65. Morganti-Kossmann, M.C., Rancan, M., Otto, VI., et al.: Role of cerebral inflammation after traumatic brain injury: a revisited concept. Shock 2001; 16: 165-177.
66. Morganti-Kossmann, M.C., Rancan, M., Stahel, P.F., et al.: Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr. Opin. Crit Care 2002; 8: 101-105.
67. Mun-Bryce, S., Lukes, A., Wallace, J., et al.: Stromelysin-1 and gelatinase A are upregulated before TNF-alpha in LPS-stimulated neuroinflammation. Brain Res 2002; 933: 42-49.
68. Nagase, H., Woessner, J.F., Jr.: Matrix metalloproteinases. J Biol. Chem 1999; 274: 21491-21494.
69. Petsko, G.A., Ringe, D.: Protein Structure and Function. Oxford University Press, 2006.
70. Petty, M.A., Lo, E.H.: Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog. Neurobiol. 2002; 311-323.
71. Plock, N., Kloft, C.: Microdialysis - theoretical background and recent implementation in applied life-sciences. Eur. J. Pharm. Sci. 2005; 25: 1-24.
72. nd. Oxford, UK: Blackwell Publishing Ltd., 2005, pp 114-126.
73. Rosdahl, H., Hamrin, K., Ungerstedt, U., et al.: A microdialysis method for the in situ investigation of the action of large peptide molecules in human skeletal muscle: detection of local metabolic effects of insulin. Int J Biol Macromol 2000; 28: 69-73.
74. Rosdahl, H., Ungerstedt, U., Henriksson, J.: Microdialysis in human skeletal muscle and adipose tissue at low flow rates is possible if dextran-70 is added to prevent loss of perfusion fluid. Acta Physiol Scand 1997; 159: 261-262.
75. Rosenberg, G.A.: Matrix metalloproteinases in brain injury. J Neurotrauma 1995; 12: 833-842.
76. Rosenberg, G.A.: Matrix metalloproteinases in neuroinflammation. Glia 2002; 39: 279-291.
77. Rosenbloom, A.J., Ferris, R.L., Sipe, D.M., et al.: In vitro and in vivo protein sampling by combined microdialysis and ultrafiltration. J. Immunol. Methods 2006; 309: 55-68.
78. Rosenbloom, A.J., Sipe, D.M., Weedn, V.W.: Microdialysis of proteins: performance of the CMA/20 probe. J Neurosci Methods 2005; 148: 147-153.
79. Ross, S.A., Halliday, M.I., Campbell, G.C., et al.: The presence of tumour necrosis factor in CSF and plasma after severe head injury. Br. J .Neurosurg. 1994; 8: 419-425.
80. Rossi, D., Zlotnik, A.: The biology of chemokines and their receptors. Annu. Rev. Immunol. 2000; 18: 217-242.
81. Rusakov, D.A., Kullmann, D.M.: Geometric and viscous components of the tortuosity of the extracellular space in the brain. Proc. Natl. Acad. Sci. U.S.A 1998; 95: 8975-8980.
82. Schmidt, O.I., Heyde, C.E., Ertel, W., et al.: Closed ead injury - an inflammatory disease? Brain Res.Brain Res. Rev. 2005; 48: 388-399.
83. Schultz, J.S., Valentine, R., Choi, C.Y.: Reflection coefficients of homopore membranes: effect of molecular size and configuration. J. Gen. Physiol 1979; 73: 49-60.
84. Schutte, R.J., Oshodi, S.A., Reichert, W.M.: In vitro characterization of microdialysis sampling of macromolecules. Anal. Chem. 2004; 76: 6058-6063.
85. Shigemori, Y., Katayama, Y., Mori, T., et al.: Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats. Acta Neurochir. Suppl 2006; 96: 130-133.
86. Singhal, A., Baker, A.J., Hare, G.M., et al.: Association between cerebrospinal fluid interleukin-6 concentrations and outcome after severe human traumatic brain injury. J Neurotrauma 2002; 19: 929-937.
87. Sjogren, F., Svensson, C., Anderson, C.: Technical prerequisites for in vivo microdialysis determination of interleukin-6 in human dermis. Br J Dermatol 2002; 375-382.
88. Snyder, K.L., Nathan, C.E., Yee, A., et al.: Diffusion and calibration properties of microdialysis sampling membranes in biological media. Analyst 2001; 126: 1261-1268.
89. Somers, W., Stahl, M., Seehra, J.S.: 1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling. EMBO J. 1997; 16: 989-997.
90. Stamatovic, S.M., Dimitrijevic, O.B., Keep, R.F., et al.: Inflammation and brain edema: new insights into the role of chemokines and their receptors. Acta Neurochir. Suppl 2006; 96: 444-450.
91. Sternlicht, M.D., Werb, Z.: How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 2001; 17: 463-516.
92. Suehiro, E., Fujisawa, H., Akimura, T., et al.: Increased matrix metalloproteinase-9 in blood in association with activation of interleukin-6 after traumatic brain injury: influence of hypothermic therapy. J Neurotrauma 2004; 21: 1706-1711.
93. Tang, A., Bungay, P.M., Gonzales, R.A.: Characterization of probe and tissue factors that influence interpretation of quantitative microdialysis experiments for dopamine. J. Neurosci. Methods 2003; 126: 1-11.
94. Tisdall, M.M., Smith, M.: Cerebral microdialysis: research technique or clinical tool. Br. J. Anaesth. 2006; 97: 18-25.
95. Torto, N., Laurell, T., Gorton, L., et al.: A study of a polysulfone membrane for use in an in-situ tunable microdialysis probe during monitoring of starch enzymatic hydrolysates. J. Membrane Sci. 1997; 130: 239-248.
96. Trickler, W.J., Miller, D.W.: Use of osmotic agents in microdialysis studies to improve the recovery of macromolecules. J. Pharm. Sci. 2003; 92: 1419-1427.
97. Ungerstedt, U., Rostami, E.: Microdialysis in neurointensive care. Curr. Pharm. Des 2004; 10: 2145-2152.
98. Vecil, G.G., Larsen, P.H., Corley, S.M., et al.: Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. J Neurosci. Res 2000; 61: 212-224.
99. th International Symposium on Intracranial Pressure and Brain Monitoring, San Francisco, USA 2007.
100. Vilalta, A., Sahuquillo, J., Rosell, A., et al.: Moderate and severe traumatic brain injury induce early overexpression of systemic and brain gelatinases. Intensive Care Med. 2008; 34: 1384-1392.
101. rd. Buenos Aires: Editorial Médica Panamericana S.A., 2006, pp 227-286.
102. Waelgaard, L., Pharo, A., Tonnessen, T.I., et al.: Microdialysis for monitoring inflammation: efficient recovery of cytokines and anaphylotoxins provided optimal catheter pore size and fluid velocity conditions. Scand. J. Immunol. 2006; 64: 345-352.
103. Wang, X., Lennartz, M.R., Loegering, D.J., et al.: Interleukin-6 collection through long-term implanted microdialysis sampling probes in rat subcutaneous space. Anal. Chem. 2007; 79: 1816-1824.
104. Wang, X., Mori, T., Jung, J.C., et al.: Secretion of matrix metalloproteinase-2 and -9 after mechanical trauma injury in rat cortical cultures and involvement of MAP kinase. J Neurotrauma 2002; 19: 615-625.
105. Wang, X., Stenken, J.A.: Microdialysis sampling membrane performance during in vitro macromolecule collection. Anal. Chem. 2006; 78: 6026-6034.
106. Wang, Y., Addess, K.J., Chen, J., et al.: MMDB: annotating protein sequences with Entrez's 3D-structure database. Nucleic Acids Res. 2007; 35: D298-D300.
107. Winter, C.D., Iannotti, F., Pringle, A.K., et al.: A microdialysis method for the recovery of IL-1beta, IL-6 and nerve growth factor from human brain in vivo. J. Neurosci. Methods 2002; 119: 45-50.
108. Winter, C.D., Pringle, A.K., Clough, G.F., et al.: Raised parenchymal interleukin-6 levels correlate with improved outcome after traumatic brain injury. Brain 2004; 127: 315-320.
109. Yoon, S.I., Logsdon, N.J., Sheikh, F., et al.: Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex. J. Biol. Chem. 2006; 281: 35088-35096.